Delivery Order SPE2DR25D2109-SPE2DR26F5ZKR
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,277.30 for Trulicity 1.5 mg/0.5 mL pen injections on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injections with a ceiling value of $1,183.02. This competitively awarded, firm fixed-price delivery order was issued on November 20, 2025, with an ultimate completion date of November 21, 2025. The contract represents a continuation of AmerisourceBergen's pharmaceutical supply services under its larger Indefinite Delivery Contract vehicle with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,860.52 for Trulicity 3 mg/0.5 ml pen (0.5 ml units) with an ultimate completion date of December 8, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a single pharmaceutical supply transaction under the company's broader federal contract portfolio. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,502.55 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on October 24, 2025, with completion expected by October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing indefinite delivery contract. The product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $3,534.20 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors on November 17, 2025, with an ultimate completion date of November 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $23,573.76 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on December 2, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 3,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors, with a ceiling value of $1,801.80 and an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,685.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5 ml) on November 12, 2025, with completion expected by November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with...
- SPE2DR25D2109Indefinite Delivery Contract
- SPE2DR25D2109-SPE2DR26F5ZKRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,932.73 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injections on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Trulicity, a diabetes medication included in the company's extensive federal contract portfolio, exemplifies the specialized pharmaceutical commodities delivered through this strategic contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 12/7/25 |